Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The role of physicians and researchers in the medical community

Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
The role of physicians and researchers in the medical community ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013

Achievements of the WIN Consortium

Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Achievements of the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013

Goal of the 2013 WIN Symposium

Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013

Myeloma UK

Eric Low - Chief Executive, Myeloma UK
Myeloma UK ( Eric Low - Chief Executive, Myeloma UK )
6 Apr 2013

Challenging paradigms in multiple myeloma

Prof Antonio Palumbo - University of Torino, Italy
Challenging paradigms in multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
6 Apr 2013

Whole genome sequencing reveals underlying genetics of multiple myeloma

Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA
Whole genome sequencing reveals underlying genetics of multiple myeloma ( Dr Jonathan Keats - The Translational Genomics Research Institute (TGen), Phoenix, USA )
4 Apr 2013

Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia

Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
13 Dec 2012

Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant

Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
13 Dec 2012

Potential targets and complications of apoptosis and necrosis

Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA
Potential targets and complications of apoptosis and necrosis ( Dr Doug Green – St Jude Children’s Research Hospital, Memphis, USA )
7 Dec 2012

Personalised medicine in metastatic colorectal cancer

Dr Alberto Villanueva – Catalan Institute of Oncology – IDIBELL, Barcelona, Spain
Personalised medicine in metastatic colorectal cancer ( Dr Alberto Villanueva – Catalan Institute of Oncology – IDIBELL, Barcelona, Spain )
7 Dec 2012

Prognostic signatures in colon cancer

Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain
Prognostic signatures in colon cancer ( Dr Ramon Salazar – Catalan Institut of Oncology, Barcelona, Spain )
7 Dec 2012

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012